We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Tells Baxter To Tone Down Aralast Claims

Law360 (September 1, 2010, 3:31 PM EDT) -- The U.S. Food and Drug Administration has issued a warning letter chastising Baxter International Inc. for overstating the effectiveness of Aralast, a lung therapy for patients at risk for a form...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.